Title:
CRYSTALLINE FORM OF CAPSID PROTEIN ASSEMBLY INHIBITOR CONTAINING N HETERO FIVE-MEMBERED RING, AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/058002
Kind Code:
A1
Abstract:
Disclosed by the present application is a crystalline form of a capsid protein assembly inhibitor containing an N hetero five-membered ring; specifically disclosed is the crystalline form of the compound of formula I; also comprised is an the application of said crystalline form in the preparation of a drug for preventing or treating diseases benefiting from the inhibition of capsid protein assembly.
Inventors:
LU YIN (CN)
GUO MENG (CN)
HU MINGTONG (CN)
LI YUAN (CN)
AO WANGWEI (CN)
ZHANG YINSHENG (CN)
GUO MENG (CN)
HU MINGTONG (CN)
LI YUAN (CN)
AO WANGWEI (CN)
ZHANG YINSHENG (CN)
Application Number:
PCT/CN2020/118427
Publication Date:
April 01, 2021
Filing Date:
September 28, 2020
Export Citation:
Assignee:
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN)
International Classes:
A61K31/40; C07D207/34; A61P31/20
Domestic Patent References:
| WO2019185016A1 | 2019-10-03 | |||
| WO2020151252A1 | 2020-07-30 | |||
| WO2019241292A1 | 2019-12-19 | |||
| WO2019165374A1 | 2019-08-29 |
Foreign References:
| CN105980378A | 2016-09-28 | |||
| CN105431413A | 2016-03-23 | |||
| CN109153640A | 2019-01-04 |
Other References:
MAYUR BRAHMANIA ET AL., NEW THERAPEUTIC AGENTS FOR CHRONIC HEPATITIS B
Attorney, Agent or Firm:
INSIGHT INTELLECTUAL PROPERTY LIMITED (CN)
Download PDF: